.
MergerLinks Header Logo

New Deal


Announced

Completed

Charlotte's Web completed the acquisition of Abacus Health Products for $69m.

Financials

Edit Data
Transaction Value£59m
Consideration TypeOrdinary Shares
Capital Owned-
Capital Bid For100%
EV/Sales4.9x
EV/EBITDA-
Share Price Premium38%
One Off Charge-

Tags

Edit

pharmaceutical company

Canada

Pharmaceuticals

Majority

Merger

Public

Single Bidder

Acquisition

Friendly

Completed

Domestic

Synopsis

Edit

Charlotte's Web, a provider of hemp-based, cannabinoid wellness products, completed the acquisition of Abacus Health Products, which produces pain relief pharmaceutical products, for $69m. "The complementary strengths of our relative market positions made this merger a logical strategic move. With this acquisition we strengthen the business to reflect the evolution of the category. Because most of Abacus's products are positioned in adjacent categories, our combined distribution reach has limited shelf overlap. Together we are the most developed CBD company across every channel and segment and positioned to accelerate our growth and extend our market share. Furthermore, it enables us to drive more scale production through our vertically integrated infrastructure," Deanie Elsner, Charlotte's Web CEO.

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US